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background: Endometriosis is a heritable common gynaecological condition inﬂuenced by multiple genetic and environmental factors.
Genome-wide association studies (GWASs) have proved successful in identifying common genetic variants of moderate effects for various
complex diseases. To date, eight GWAS and replication studies from multiple populations have been published on endometriosis. In this
review,we investigate the consistency and heterogeneity of the results across all the studies and their implications for an improved understanding
of the aetiology of the condition.
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methods: Meta-analyses were conducted on four GWASs and four replication studies including a total of 11 506 cases and 32 678 controls,
and on the subset of studies that investigated associations for revisedAmerican Fertility Society (rAFS) Stage III/IV including 2859 cases. The data-
sets included 9039 cases and 27 343 controls of European (Australia, Belgium, Italy, UK, USA) and 2467 cases and 5335 controls of Japanese
ancestry. Fixed and Han and Elkin random-effects models, and heterogeneity statistics (Cochran’sQ test), were used to investigate the evidence
of the nine reported genome-wide signiﬁcant loci across datasets and populations.
results:Meta-analysis showed that sevenout of nine loci had consistent directions of effect across studies andpopulations, and six out of nine
remained genome-wide signiﬁcant (P, 5 × 1028), including rs12700667 on 7p15.2 (P ¼ 1.6 × 1029), rs7521902 near WNT4 (P ¼ 1.8 ×
10215), rs10859871 near VEZT (P ¼ 4.7 × 10215), rs1537377 near CDKN2B-AS1 (P ¼ 1.5 × 1028), rs7739264 near ID4 (P ¼ 6.2 × 10210)
and rs13394619 in GREB1 (P ¼ 4.5 × 1028). In addition to the six loci, two showed borderline genome-wide signiﬁcant associations with
Stage III/IV endometriosis, including rs1250248 in FN1 (P ¼ 8 × 1028) and rs4141819 on 2p14 (P ¼ 9.2 × 1028). Two independent inter-
genic loci, rs4141819 and rs6734792 on chromosome 2, showed signiﬁcant evidence of heterogeneity across datasets (P, 0.005). Eight of
the nine loci had stronger effect sizes among Stage III/IV cases, implying that they are likely to be implicated in the development of moderate
to severe, orovarian, disease.While three out of nine lociwere inter-genic, the remainingwere in or near geneswith known functions of biological
relevance to endometriosis, varying from roles in developmental pathways to cellular growth/carcinogenesis.
conclusions: Our meta-analysis shows remarkable consistency in endometriosis GWAS results across studies, with little evidence of
population-based heterogeneity. They also show that the phenotypic classiﬁcations used in GWAS to date have been limited. Stronger associa-
tionswith Stage III/IV disease observed formost loci emphasize the importance for future studies to include detailed sub-phenotype information.
Functional studies in relevant tissues are needed to understand the effect of the variants on downstream biological pathways.
Key words: endometriosis / genetics / GWAS / sub-phenotypes / heterogeneity
Introduction
Endometriosis is a common, estrogen-dependent, inﬂammatory condi-
tion associated with chronic pelvic pain, subfertility and dysmenorrhoea
(Giudice and Kao, 2004; Berkley et al., 2005). Its estimated prevalence
rates range from 5–10% in women of reproductive age in the general
population to 35–50% among women with chronic pelvic pain and
subfertility (Eskenazi and Warner, 1997). The causes of the condition
are largely unknown, but are likely to be complex, involving multiple
environmental and genetic factors. Based on a study of 3096 twins, the
heritability of endometriosis, the proportion of disease variance due to
genetic factors, has been estimated at around 52% (Treloar et al., 1999).
To elucidate causal genetic variants underlying endometriosis, many
investigators have used so-called ‘candidate gene’ study approaches
over the past decades. Candidate gene study approaches are based on
ahypothesis,which canbebiological or positional. In biological candidate
gene studies, genes with an inferred biological relevance to the disease
are selected and genetic variants in these genes are tested for association
with the disease of interest. In positional candidate gene studies, variants
and genes are selected on the basis of prior evidence that a speciﬁc
genomic region is implicated, for example through hypothesis-free
linkage studies described below. Few such positional candidate gene
studies have been performed in endometriosis (Treloar et al., 2007;
Zhao et al., 2008; Lin et al., 2011). Biological candidate gene studies in
endometriosis have been abundant and, similar to other complex dis-
eases, it is fair to say that they have been generally unsuccessful, with
limited replicated results (Montgomery et al., 2008; Rahmioglu et al.,
2012). Reasons for the general failure of candidate gene studies to eluci-
date genetic mechanisms in complex disease are clear: (i) they are based
on a biological hypothesis that may not be true; (ii) only one or a few
genes in a relevant biological pathway are typically tested; (iii) usually
only a few variants in a gene are tested, and no attempt is made to com-
prehensively cover the gene; (iv) cases andcontrols usedareoftenpoorly
deﬁned, or deﬁnitions vary and (v) sample sizes are usually inadequate to
detect the effect sizes that are expected for variants inﬂuencing a
complex trait (Zondervan et al., 2002).
Rather than following hypotheses with little a priori probability of
success, many investigators have turned to hypothesis-free approaches
to uncover genetic variants underlying disease on a genome-wide
scale. There are two such hypothesis-free approaches: (i) family-based
linkage studies and (ii) population-based genome-wide association
studies (GWASs). Family-based linkage studies are aimed at identifying
genomic regions harbouring genetic variants that are typically rare in
the general population, and responsible for the aggregation of a
disease in families with multiple affected individuals.
Linkage studies have been very successful in identifying genetic
variants responsible for rare, monogenic disorders, in which a mutation
confers a very high risk of disease, but they have not generally been very
successful in complex diseases, where genetic variants confer modest
increases in susceptibility to disease. Exceptions are scenarios in
which families are identiﬁed with strong familial aggregation of what is
generally considered a complex disease. A well-known example of
such a scenario is the identiﬁcation of the BRCA genes habouring rare
variants conferring high risk of familial breast and ovarian cancer
(Easton, 1999; Pal et al., 2005; Campeau et al., 2008). In 2005, the Inter-
national Endogene Study published evidence of signiﬁcant linkage of
endometriosis to chromosome 10q26 from analysis of 1176 affected
sister-pair families (Treloar et al., 2005); subsequent ﬁne-mapping asso-
ciation analyses of 10q26 suggested possible association of common
variants near CYP2C19 (Painter et al., 2011a, b), but rare variants that
could explain the linkage signal remain to be identiﬁed. In 2007, the
same study identiﬁed signiﬁcant linkage to chromosome 7p13-15 in
a sub-analysis of 248 families with more than 3 affected members
(Zondervan et al., 2007), suggesting the presence of one or more rare
variants conferring high risk; analyses are ongoing to identify the variants
responsible (Lin et al., 2011).
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Population-basedGWASs are founded on the principle that common
diseases, such as endometriosis, are caused by genetic variants that are
common themselves (common disease-common variant hypothesis).
Thus, they can be seen as a complementary approach to linkage
studies, which are designed to ﬁnd rare variants contributing to familial
disease. The principle of GWAS is simple, in that a set of several
100 000 common single nucleotide polymorphisms (SNPs or single
DNA base pair changes), selected to provide the maximum coverage
of the genome, is genotyped in a large set of cases and controls and
their frequencies are compared between the two groups. This SNP se-
lection is based on ‘linkage disequilibrium’ (LD) between SNPs, which
is the non-random correlation of genetic variants in a population that
exists due to shared ancestry of chromosomes. SNPs selected to ‘tag’
(represent) parts of the genome can be used to predict the allelic
status of a genetic variant nearby because of shared ancestry of that par-
ticular genomic segment. Thus, several 100 000 s of tagSNPs canbeused
to provide information on most of the 10 million common SNPs
present in the human genome. In the past 5 years, GWAS have proved
to be very successful in identifying many common genetic variants asso-
ciated with complex disease, as demonstrated by the NHGRI Catalog
of published GWAS (http://www.genome.gov/gwastudies/; Fig. 1)
(Hindorff et al., 2009; Visscher et al., 2012). The current catalogue
includes association results for11 751SNPs from1738publications (No-
vember 2013). Notably, 88% of identiﬁed SNPs are either in inter-genic
regions (43%) or located in intronic (non-coding) regions (45%) of genes,
demonstrating that the interpretation of the signals typically requires
further studies exploring the functionality of these regions (Hindorff
et al., 2009). Indeed, theENCODEproject has shownthat80%ofnon-
coding regions are likely to have functionality regulating gene expression
(ENCODE Project Consortium, 2012).
GWAS of endometriosis
In 2010, the ﬁrst endometriosis GWAS was published on a Japanese
dataset of 1907 cases and 5292 controls (Uno et al., 2010), providing
genome-wide signiﬁcant evidence for association of a variant in
CDKN2B-AS1 (cyclin-dependent kinase inhibitor 2B antisense RNA)
[rs10965235; odds ratio (OR) ¼ 1.44 (95% conﬁdence interval (CI):
1.30–1.59), P ¼ 5.57 × 10212]. This publication was quickly followed
by that of a smaller Japanese GWAS of 696 cases and 825 controls
that did not ﬁnd a signiﬁcant signal (Adachi et al., 2010). The ﬁrst
GWAS in women of European ancestry was published in 2011 by the
Figure 1 Schematic overview of all genome-wide associations (P ≤ 5 × 1028) across all chromosomes (small window) and endometriosis associations
(large window), presented in 17 trait categories (colour coded), generated from the NHGRI GWA Catalog (Hindorff et al., 2009). Available at: www
.genome.gov/gwastudies (accessed 11 October 2013).
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International EndogeneConsortium (IEC), involving 3194 surgically con-
ﬁrmed cases and 7060 controls from Australian and UK datasets, with
independent replication in a US dataset of 2392 cases and 2271 controls
(Painter et al., 2011a, b). This study provided genome-wide signiﬁcant
evidence for an inter-genic locus on chromosome 7 [rs12700667;
OR ¼ 1.22 (95% CI: 1.13–1.32), P ¼ 1.4 × 1029], and combined
with the published results from Uno et al. (2010), for association with
an SNP near WNT4 (wingless-type MMTV integration site family
member 4) [rs7521902; OR ¼ 1.19 (95% CI: 1.12–1.27), P ¼ 4.2 ×
1028]. Both signals showed much stronger evidence for association
with moderate-to-severe [revised American Fertility Society (rAFS)
Stage III/IV] endometriosis: rs12700667, OR¼ 1.38 (95% CI: 1.24–
1.53); rs7521902: OR¼ 1.25 (95% CI: 1.12–1.27). The IEC study could
not replicate the signal for rs10965235 seen in the Japanese GWAS by
Uno et al. (2010), as this variant was monomorphic (non-variable) in indivi-
duals of European ancestry, nor could they ﬁnd association with variants
nearby. In2012,ameta-analysisof summary results, combining theevidence
from the Japanese and IEC GWAS datasets, was conducted. This analysis
conﬁrmed the three loci published by the twooriginal papers, and provided
evidence for a further four (Nyholt et al., 2012): rs10859871 near VEZT
[OR¼ 1.20 (95% CI: 1.14–1.26); P¼ 5.1× 10213]; rs4141819 in an
inter-genic region on 2p14 [OR¼ 1.15 (95% CI: 1.09–1.21), P¼ 8.5×
1028]; rs7739264 near ID4 (inhibitor of DNA binding 4) [OR ¼ 1.17
(95% CI: 1.11–1.23), P¼ 3.6× 10210] and rs1537377 near
CDKN2B-AS1 [OR¼ 1.15 (95% CI: 1.10–1.21), P¼ 2.4× 1029].
Since theNyholt et al. (2012)meta-analysis, a fourthGWAS inwomen
of European ancestry was published, involving 2019 cases and 14 471
controls from theUSA (Albertsen et al., 2013). This large study reported
lackof signiﬁcant replication of the IEC signal for rs12700667on chromo-
some 7 (P ¼ 0.12), and found two genome-wide signiﬁcant signals: (i)
near WNT4 (rs2235529; P ¼ 8.65 × 1029), tagging the same locus for
which association was reported by the IEC/Japanese meta-analyses
(r2 ¼ 0.66 with rs7521902) and (ii) a novel intergenic signal 280Kb up-
stream of RND3-RBM43 (rs1519761; P ¼ 4.70 × 1028). In addition,
two replication studies were published, which genotyped some of the
implicated SNPs in women of European ancestry. A study involving
1129 surgically conﬁrmed cases and 831 controls from Belgium (Sundq-
vist et al., 2013) did not ﬁnd signiﬁcant evidence either for rs12700667on
chromosome 7 (P ¼ 0.46), or for rs7521902 in WNT4 (P ¼ 0.17).
A second replication study in 305 surgically conﬁrmed cases and 2710
controls from Italy (Pagliardini et al., 2013) also could not replicate
rs12700667 (P ¼ 0.80) but did ﬁnd signiﬁcant evidence for WNT4
(rs7521902, P ¼ 5.6 × 1023), FN1 (ﬁbronectin 1) (rs1250248, P ¼
9.0 × 1023) and an SNP in CDKN2B-AS1 (rs1333049, P ¼ 1.7 ×
1023). Results in these more recent papers have been interpreted as
showing evidence for heterogeneity in the genetic loci underlying endo-
metriosis in different populations, evenwhen sampled fromwomenwith
similar ethnic ancestry.
Sources of heterogeneity
Genetic population heterogeneity
Association studies assume that the allele frequency differences of
genetic variants (SNPs) observed between cases and controls reﬂect
genetic factors underlying the disease. Common SNPs (population
allele frequency.0.05) genotyped throughout the genome for the asso-
ciation studies are selected on the basis of LD. Different patterns of LD
exist between populations due to differing mutational events and selec-
tion pressures experienced by different populations throughout history.
The International HapMap Project has determined LD patterns of SNPs
across the genome through characterizing the genetic variants, and their
frequencies and correlations, in DNA samples from 11 different ethnic
populations (The International HapMap Consortium, 2005, 2010).
This has enabled the discovery of common genetic risk variants indirectly
through testing tagSNPs that are highly predictive of the status of other
SNPs, providing very dense coverage of the genomewithout genotyping
all the variants in the region of interest, in each reference population.
Due to population history differences, some of the disease risk var-
iants implicated in one ethnic populationmay not be associated, or asso-
ciated with a greater or lesser extent, with disease risk in another
population. This problem is worse for more recent mutations, deleteri-
ousmutations that are found at lower frequencies andwhich tend not to
be shared between populations (making most of the rare mutations
private to different ethnic populations), or those that affect traits with
reduced reproductive ﬁtness/fertility. Arguably, endometriosis could
be an example of such a trait, although it is unknown whether endomet-
riosis would have affected the fertility of women in early reproductive
years in previous centuries.
Phenotypic heterogeneity: disease deﬁnition
Variability in phenotypic characterization of endometriosis cases
between studies is likely to contribute to the heterogeneity in ﬁndings,
and may result in genetic risk variants going undetected due to dilution
of the strength of association. Variabilitymay arise because of differences
in the proportions of endometriosis sub-phenotypes such as endome-
trioma, recto-vaginal and peritoneal disease, or different frequencies of
rAFS stage (American Society for Reproductive Medicine, 1997), which
mayhavedifferent geneticorigins. Inaddition, someGWASshave included
endometriosis cases thatwerediagnosed throughmethodsother than the
gold standard of laparoscopic surgery, such as ultra-sound imaging or clin-
ical symptoms. Furthermore, women with endometriosis in the studies
may vary according to pain or subfertility phenotypes which, if available
at all, are likely to have been assessed through different, non-standardized,
means. Also, the route to diagnosis can vary greatly between clinics and
countries, due to referral patterns and cultural and socio-economic differ-
ences, all of which could introduce heterogeneity in terms of the type of
cases that are included in the studies.
Given the suggested heterogeneity in genetic signals from endometri-
osis GWAS and replication studies, and the potential for genetic and
phenotypic variability to inﬂuence results,we investigated theheterogen-
eity and consistency of results across all publishedGWAS and replication
datasets from Australia, Belgium, Italy, Japan, the UK and the USA
through meta-analyses of 11 SNPs in 9 loci that reached genome-wide
signiﬁcance in at least 1 study.
Methods
Descriptions of GWAS and replication studies
and populations
For this meta-analysis, we identiﬁed all the GWAS of endometriosis and rep-
lication studies published up to 1 December 2013. A systematic literature
search in PubMed for English language publications was performed using
the terms ‘endometriosis’ and ‘GWAS’ and/or ‘replication’. Table I shows
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all fourGWASand four replicationdatasets included in themeta-analysis, and
their populationorigins.OneGWASdatasetwasof Japaneseorigin, and con-
sisted of 1423 case and 1318 controls obtained from the BioBank Japan (Uno
et al., 2010). Individuals were genotyped on the Illumina 550 K BeadChip
array. Cases were diagnosed through the presence of multiple clinical symp-
toms, physical examinations and/or laparoscopic surgery; no information on
disease stage or other sub-phenotypic disease data was available. The
remaining threeGWAS datasets are of European ancestry, with all cases lap-
aroscopically conﬁrmed: 2270 (40% rAFS Stage III/IV) cases and 1870 con-
trols fromAustralia (‘QIMR’); 924 (49% Stage III/IV) cases and 5190 controls
from theUK (‘OX’) (Painter et al., 2011a), and 2019 (42% Stage III/IV) cases
and 14 471 controls from the USA (‘UTAH’) (Albertsen et al., 2013). The
control sets in all GWAS datasets were population based and unscreened
for endometriosis cases. The IEC Australian and UK datasets were geno-
typed on Illumina 610/670 K and 670 K/1M chips, respectively, while the
US dataset was genotyped using Illumina OmniExpress 730 K BeadChip.
The IEC datasets were imputed up to 1000 Genomes Pilot reference panel
(B36, June 2010). From the SNPs included in this meta-analysis, only
rs1333049 was an imputed SNP in the QIMR Australian dataset.
Of the four replication studies, onewas conducted in women of Japanese,
and three inwomen of European ancestry (Table I). The datasets comprised:
(i) 2392 self-reported surgically diagnosed cases (no disease stage informa-
tion) and 2271 unscreened population controls from the Nurse’s Health
Study II (NHS II) in the USA (Painter et al., 2011a); (ii) 305 laparoscopically
conﬁrmed cases (72% Stage III/IV cases) and 2710 population-based con-
trols (90% unscreened for endometriosis) from Italy (Pagliardini et al.,
2013); (iii) 1129 laparoscopically conﬁrmed cases (38% stage III/IV cases)
and 831 laparoscopy-negative controls from a subfertility clinic population
in Belgium (Sundqvist et al., 2013) and (iv) 1044 cases (no disease stage infor-
mation) and 4017 unscreened population controls from BioBank Japan (Uno
et al., 2010); 653 of these 1044 cases had been used in a small GWAS of 696
cases and 825 controls, which had not provided a genome-wide signiﬁcant
result (Adachi et al., 2010).
Meta-analysis of genome-wide signiﬁcant
results across the studies
We performed a meta-analysis of association results for SNPs passing the
P-value threshold, 5 × 1028 (‘genome-wide signiﬁcance’) in at least one
of the studies, across all of theendometriosisGWASand replicationdatasets,
including a total of 11 506 cases and 32 678 controls, employing a ﬁxed-effect
model in the ﬁrst instance, usingGWAMAsoftware (Ma¨gi andMorris, 2010).
ORs and 95%CIs and the sample size of the studies for each SNPwere used
as input to the model. SNPs that maintained a P-value , 5 × 1028 on
meta-analysis were considered genome-wide signiﬁcant. Given the evidence
for a substantially increased contribution of genetic factors to moderate/
severe (rAFS Stage III/IV) compared with minimal/mild (rAFS Stage I/II)
endometriosis (Painter et al., 2011a, b), additional meta-analyses were
conducted on ‘Stage III/IV enriched’ and ‘Stage III/IV only’ datasets. The
‘Stage III/IV-enriched’ analysis included association results from QIMR,
OX, UTAH, Pagliardini and Sundqvist Stage III/IV cases (n ¼ 2859) versus
controls, combined with all-stage endometriosis versus controls association
results from the BBJ, BBJ replication and NHS II replication datasets
(for which stage information on cases was not available). Thus, the ‘Stage
III/IV-enriched’ analysis was based on 7718 cases and 32 678 controls.
The Stage III/IV-only analysis included association results from 2859 Stage
III/IV cases (QIMR, OX, UTAH, Pagliardini and Sundqvist) versus 32 678
controls.
Heterogeneity of allelic effects across studies was examined using the
Cochran’s Q test (Cochran, 1954). Between-study heterogeneity was indi-
cated by Q statistic P values , 0.1 (Ioannidis et al., 2007), as well as the I2
index, which indicates the percentage of variance attributable to heterogen-
eity (Higgins and Thompson, 2002). Given that the nine loci represented
nine independent tests, a Bonferroni correction (0.05/9) was applied
to the threshold for signiﬁcant evidence of heterogeneity (P, 0.005).
Meta-analysis of SNPs that showed evidence of effect heterogeneity was
also carried out using the Han and Eskin random-effects model, which
increases power to detect associations under heterogeneity, implemented
in METASOFT software (Han and Eskin, 2011). Beta effect sizes, standard
errors and sample sizes for each SNP were used for input to the model.
The variance explained by the established loci associated with endometri-
osis was calculated by transformation of dichotomous disease risk onto
a continuous liability scale that assumes a disease prevalence rate and a
multiplicative model (Wray et al., 2010; Morris et al., 2012).
Investigation of other reported GWAS
associations in endometriosis loci
For each endometriosis SNP included in the meta-analysis, we determined
the chromosomal band it is located in, using UCSC build 19. We then
extracted all GWAS that reported genome-wide signiﬁcant SNP associations
with any disease or trait for the respective chromosomal segments from the
.............................................................................................................................................................................................
Table I Summary of the eight published endometriosis GWAS and replication studies included in the meta-analysis.
Cohort Ancestry No. of cases No. of stage III/IV casesa No. of controls References
OX GWAS European (UK/USA/EU) 924 454 5190 Painter et al. (2011a)
QIMR GWAS European (Australia) 2270 908 1870 Painter et al. (2011a)
Utah GWAS European (USA) 2019 848 14 471 Albertsen et al. (2013)
NHS II replication European (USA) 2392 No stage info 2271 Painter et al. (2011a)
Pagliardini replication European (Italy) 305 220 2710 Pagliardini et al. (2013)
Sundqvist replication European (Belgium) 1129 429 831 Sundqvist et al. (2013)
Total European ancestry 9039 2859 27 343
BBJ GWAS Japanese 1423 No stage info 1318 Uno et al. (2010)
BBJ replication Japanese 1044 No stage info 4017 Uno et al. (2010)
Total Japanese ancestry 2467 5335
Total 11 506 2859 32 678
arAFS III and IV disease only. OX, Oxford University; QIMR, Queensland Institute of Medical Research; NHS II, Nurses’ Health Study II; BBJ, BioBank Japan.
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NHGRI resource (http://www.genome.gov/gwastudies/) (Hindorff et al.,
2009). We determined the distance between each endometriosis SNP and
SNPs associated with other diseases/traits in each chromosomal segment,
and assessed LD (correlation, r2) between each SNP pair in the Caucasian
and Japanese populations using the 1000 Genomes Pilot CEU and JPT data
reference panels, implemented in Haploview (Barrett et al., 2005). An
r2. 0.2 was used as the threshold for SNPs that were in moderate LD
(1000 Genomes Project Consortium, 2010).
Results
Consistency and heterogeneity of genetic
associations between studies and populations
Of the 11 SNPs in 9 loci associated with endometriosis in at least one of
the 8 studies, the meta-analysis showed genome-wide signiﬁcant evi-
dence (P, 5 × 1028) for seven SNPs (six loci), with consistent direc-
tions of effect across studies and populations (Table II, Fig. 2). These
included rs7521902 nearWNT4 [OR ¼ 1.18 (95% CI: 1.13–1.23) P ¼
1.8 × 10215]; rs13394619 in GREB1 (growth regulation by estrogen in
breast cancer 1) [OR ¼ 1.13 (95% CI: 1.07–1.20), P ¼ 2.9 × 1028];
rs7739264 near ID4 [OR ¼ 1.11 (95% CI: 1.08–1.15), P ¼ 6.2 ×
10210]; both rs12700667 [OR ¼ 1.10 (95% CI: 1.06–1.14), P ¼
1.6 × 1029] and rs7798431 [OR ¼ 1.13 (95% CI: 1.09–1.18), P ¼
5.4 × 1029] in an inter-genic region on chromosome 7 (correlation r2
between SNPs ¼ 0.8); rs1537377 near CDKN2B-AS1 [(OR ¼ 1.12
(95% CI: 1.08–1.17), P ¼ 1.0 × 1028] and rs10859871 [OR ¼ 1.18
(95% CI: 1.13–1.22), P ¼ 4.8 × 10215] in VEZT. Interestingly,
rs1250248 in FN1 showed a strong association with Stage III/IV
disease (P ¼ 8.0 × 1028), had consistent directions of effect across all
studies and populations, but just fell short of the genome-wide signiﬁ-
cance threshold.
The results show that genetic heterogeneity betweenpopulations is not
governing these six conﬁrmed endometriosis loci. For three of the seven
SNPs, the between-study heterogeneityQ test P-valuewas borderline sig-
niﬁcant (0.01, P, 0.1) when considering that nine independent tests
were conducted; however, the results from the random-effects model
allowing for heterogeneity showed negligible difference from those
obtained using ﬁxed-effectmeta-analysis, and they reached genome-wide
signiﬁcance under both models, demonstrating the lack of evidence for
signiﬁcant heterogeneity of signals between studies (Table II). One of
the directionally consistent loci is rs12700667, in an inter-genic region
of high LD (48Kb r2. 0.8) with rs7798431 on chromosome 7. The pre-
viously reported lack of signiﬁcant association of rs12700667 and
rs7798431 variants in the individual Belgian (Sundqvist et al., 2013),
Italian (Pagliardini et al., 2013) and Utah datasets (Albertsen et al., 2013)
is therefore likely to be due to stochastic ﬂuctuations that typically
can be seen between individual datasets. It also highlights an important
point about the need to interpret study results as probabilities, and
demonstrates the complex issue of what (lack of) ‘replication’ means
when a ﬁxed P-value threshold such as P, 0.05 is used. A variant with
an association P. 0.05 does not imply the variant is not associated;
rather, it means that, assuming the variant has no effect, if we conducted
the same study 100 times, we would see the result in at least 5% of
instances.
Two inter-genic loci, both on chromosome 2, showed evidence of
heterogeneity (P, 0.005) between studies: rs4141819 (closest gene:
ETAA1) and rs6734792 (closest gene: RND3). Random-effects analyses
substantially increased the signiﬁcance of rs4141819, most notably for
association with Stage III/IV disease (enriched analysis: P ¼ 9.2 ×
1028), but had little effect on association with rs6734792 (all endomet-
riosis: P ¼ 2.2 × 1026).
An intriguing genomic region, because of the differences in allele
frequencies and LD structure between individuals of Japanese and
European ancestry, is the CDKN2B-AS1 locus on chromosome 9
(Table II, Fig. 3). In the ﬁrst Japanese GWAS of endometriosis by Uno
et al. (2010), the authors reported association with rs10965235 in
CDKN2B-AS1 gene. This SNP, however, is monomorphic in individuals
of European ancestry, and therefore direct replication of this signal was
not possible in datasets of this ancestry. However, in the Nyholt et al.
meta-analysis of the BBJ, QIMR and OX datasets, genome-wide signiﬁ-
cant association was reported across these datasets for rs1537377
[P ¼ 1.0 × 1028, OR ¼ 1.22 (95% CI: 1.14–1.30], 55 kb away from
rs10965235. LD (correlation) between rs10965235 and rs1537377 in
the Japanese HapMap reference population is very low (r2 ¼ 0.01)
(Fig. 3). Nyholt et al. (2012) conducted conditional association analysis
in the Japanese dataset, providing suggestive evidence for rs1537377
to be a second, independent, risk variant in the CDKN2B-AS1 region
for endometriosis. Our present meta-analysis certainly suggests that
rs1537377 is a risk variant across Japanese and European ancestry
datasets, showing the strongest association with Stage III/IV disease
(Stage III/IV enriched: P ¼ 5.8 × 10212). In the Italian replication
study, Pagliardini et al. genotyped rs1333049 in the CDKN2B-AS1
region, based on its location in the same Japanese LD block as
rs10965235 (Fig. 3) and on its common frequency in the Italian popula-
tion [HapMap minor allele frequency in Tuscans in Italy (TSI) ¼ 0.48].
In our meta-analysis including unpublished data from UK (OX GWAS)
and Australian (QIMR GWAS) datasets, rs1333049 did not reach
genome-wide signiﬁcance (Stage III/IV enriched: P ¼ 0.05).
Assuming a population prevalence for endometriosis of 8%
(Zondervan et al., 2001, 2002; Missmer et al., 2004), these nine loci
together account for 1.67% of variance in ‘all’ endometriosis suscep-
tibility (Wray et al., 2010). Therefore, they currently have no immedi-
ate role in risk prediction.
Results for clinical sub-phenotypes
Of the seven genome-wide signiﬁcantly associated SNPs in our
meta-analysis (six loci), six SNPs (ﬁve loci) showed an increasing effect
size (OR) as the proportion of cases with Stage III/IV disease included
in analyses increased from all endometriosis to ‘Stage III/IV-enriched’
to ‘Stage III/IV-only’ (Table II). Figure 2 shows forest plots for the
results of these loci from individual studies, for association with all
endometriosis and Stage III/IV disease, highlighting the point that for
most loci, effect sizes were greater for association with Stage III/IV
disease. These results imply that the loci are likely to be implicated pre-
dominantly in the development of moderate/severe disease. The most
striking observation of an association that became close to genome-wide
signiﬁcance when limiting cases to the much smaller subset with known
Stage III/IV disease (n ¼ 2859) is rs1250248 in FN1, which had an asso-
ciation OR ¼ 1.11 (95% CI: 1.04–1.18, P ¼ 1.1 × 1024) with all endo-
metriosis, and anORof 1.27 (95%CI: 1.16–1.38),P ¼ 8.0 × 1028)with
Stage III/IV disease.
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Table II Results of the meta-analysis of the 11 published SNPs genome-wide signiﬁcantly associated with endometriosis in at least one study.
Chr SNP Position
(HG19)
RA RAF in
CEU
RAF in
JAP
Case
selectione
No. of
studies
Meta-analysis results Nearest
gene
Pmeta
b Direction Q
Phet
I2** ORMeta
(95% CI)
(distance)
1 rs7521902a 22490474 A 0.23 0.33 All 7 1.8 × 10215 +++++++ 0.83 0 1.18 (1.13–1.23) WNT4
III/IV enriched 7 2.7 × 10217 +++++++ 0.81 0 1.23 (1.17–1.28) (21 kb)
III/IV only 4 1.8 × 10210 ++++ 0.80 0 1.25 (1.16–1.33)
2 rs13394619c 11727257 G 0.53 0.42 All 6 4.5 × 1028 (2.9 × 1028) ++++++ 0.04* 56.1 1.13 (1.07–1.20) GREB1
III/IV enriched 6 3.5 × 1028 ++++++ 0.13 39.8 1.15 (1.09–1.20) (0)
III/IV only 3 2.1 × 1023 +++ 0.34 25.6 1.18 (1.11–1.24)
2 rs4141819 67864425 C 0.27 0.22 All 5 2.1 × 1024 (8.8 × 1026) ++++2 0.004* 70.6 1.08 (1.04–1.12) Intergenic
III/IV enriched 5 2.5 × 1025 (9.2 × 1028) ++++2 0.02* 66.0 1.15 (1.09–1.21) (ETAA1:
III/IV only 3 6.9 × 1026 (1.0 × 1026) +++ 0.003* 81.9 1.16 (1.09–1.24) 227 kb)
2 rs1250248 216286843 A 0.21 0.03 All 6 1.1 × 1024 ++++++ 0.21 23.0 1.11 (1.04–1.18) FN1
III/IV enriched 6 1.3 × 1025 ++++++ 0.86 0 1.13 (1.07–1.19) (0)
III/IV only 3 8.0 × 1028 +++ 0.86 0 1.26 (1.16–1.38)
2 rs6734792 151624632 C 0.38 0.32 All 4 9.7 × 1025 (2.2 × 1026) +++? 0.003* 78.3 1.10 (1.06–1.16) Intergenic
III/IV enriched 4 5.5 × 1023 ++++ 0.13 49.8 1.08 (1.02–1.15) (RND3:
III/IV only 3 6.5 × 1025 (2.7 × 1025) +++ 0.002* 84.4 1.10 (1.05–1.15) 281 kb)
6 rs7739264 19785338 T 0.55 0.77 All 6 1.9 × 10210 (6.2 × 10210) ++++++ 0.05* 50.9 1.11 (1.08–1.15) ID4
III/IV enriched 6 6.7 × 10210 (3.1 × 10210) ++++++ 0.02* 61.0 1.14 (1.10–1.19) (52 kb)
III/IV only 3 1.2 × 1028 +++ 0.56 0 1.20 (1.13–1.28)
7 rs12700667 25901389 A 0.76 0.20 All 8 1.9 × 1029 (1.6 × 1029) ++++++++ 0.05* 51.0 1.13 (1.08–1.17) Intergenic
III/IV enriched 8 7.0 × 10211 (4.2 × 10211) ++++++++ 0.02* 57.9 1.17 (1.11–1.22) (NFE2L3:
III/IV only 4 4.5 × 1028 (3.6 × 1028) ++++ 0.02* 69.5 1.22 (1.14–1.31) 290 Kb)
7 rs7798431d 25860562 G 0.79 0.49 All 5 5.4 × 1029 +++++ 0.14 37.0 1.13 (1.09–1.18) Intergenic
III/IV enriched 5 8.5 × 10210 +++++ 0.15 40.8 1.19 (1.13–1.26) (NFE2L3:
III/IV only 3 9.7 × 1028 +++ 0.10 58.3 1.24 (1.14–1.33) 331 Kb)
9 rs1537377 22169450 C 0.40 0.39 All 5 1.0 × 1028 +++++ 0.30 18.8 1.12 (1.08–1.17) CDKN2B-
III/IV enriched 5 5.8 × 10212 +++++ 0.25 23.8 1.18 (1.13–1.23) AS1
III/IV only 3 8.1 × 1028 (2.3 × 1027) +++ 0.09* 58.1 1.18 (1.11–1.26) (48 Kb)
9 rs1333049 22125253 G 0.54 0.02 All 3 0.25 (0.12) ++2 0.01* 77.3 1.04 (0.98–1.10) CDKN2B-
III/IV enriched 3 0.05 (0.03) ++2 0.03* 70.9 1.08 (1.00–1.17) AS1
III/IV only 2 0.55 (0.60) ++ 0.47 0 1.03 (0.94–1.12) (4 Kb)
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Current understanding of biological
mechanisms of the genetic loci
Figure 4 depicts the genes nearest to the nine loci (eleven SNPs) analysed
in our meta-analysis, showing the location of each SNP in relation to the
gene and its functional structures. Also shown is the location of known
SNPs within the gene reported to be genome wide associated with
other traits and diseases (source: NIHGR GWAS database, http
://www.genome.gov/gwastudies/; November 2013), that are in LD
(r2. 0.2) with any of the endometriosis SNPs. A comprehensive list
of all published GWAS variants that are located in the genes but do
not correlate (r2, 0.2) with endometriosis SNPs, or are in LD with
endometriosis variants outside genes, is provided in Supplementary
data, Table SI.
A total of four SNPs in three genetic loci, rs12700667/rs7798431 on
chromosome 7p15.2, rs4141819 on 2p14 and rs6734792 on 2q23.3 are
in inter-genic regions with no known genes within 200 kb. Recent evi-
dence from the ENCODE project has strongly suggested that these
regions are likely to play an important role in gene transcription regula-
tion (The ENCODE Consortium, 2012), and variants located in these
regions may be involved in cis- or trans-regulation of genes distantly
located. Althoughwe report the genes nearest to the associated variants
(Fig. 4), this does not necessarily imply that it is the regulation of these
genes that is affected by the variants. Further studies on the effect of
the variants on gene expression (eQTL studies) are required to under-
stand how they affect biological pathways.
Intergenic rs12700667 on 7p15.2 is in high LD with rs1055144 (P ¼
1.0 × 10224; r2 ¼ 0.5, 1000G pilot CEU data; Fig. 4) thatwas previously
associated with waist-to-hip ratio adjusted for body mass index
(WHRadjBMI), a measure of fat distribution, in an independent GWAS
of 190 000 individuals (Heid et al., 2010). The 7p15.2 region contains
several potential candidate genes. NFE2L3 [Nuclear factor (erythroid-
derived 2-like 3] is a transcription factor suggested to be involved in
cell differentiation, inﬂammation and carcinogenesis (Chevillard and
Blank, 2011). NFE2L3 mRNA levels were found to be up-regulated in
human breast cancer cells (Rhee et al., 2008) and testicular carcinoma
tissue samples (Almstrup et al., 2007). Also, interferon-gamma has
been shown to increase NFE2L3 mRNA levels in human uterine endo-
thelial cells (Kitaya et al., 2007). However, its potential role in endomet-
riosis aetiology remains to be discovered. A second locus of interest in
this region is a microRNA, miRNA_148a, with a purported role in the
Wnt/b-catenin signaling pathway (Qin et al., 2010).Wnt/b-catenin sig-
naling has an important role in communication between epithelial and
stromal cells in endometrium (Tulac et al., 2003), and may have a role
in endometriosis-related infertility, and/or its development through
sex hormone homeostasis regulation (Matsuzaki et al., 2010; Wang
et al., 2010) and ﬁbrogenesis (Matsuzaki and Darcha, 2013). In vitro
studies have also shown that, through targeting Wnt/b-catenin
pathway, cellular mechanisms known to be involved in endometriotic
lesion development, such as cell proliferation, migration and invasion
of endometrial and endometriotic epithelial and stromal cells, can be
inhibited (Matsuzaki and Darcha, 2013). Moreover, the Wnt/
b-catenin pathway is involved in development, tissue self-renewal and
in various cancers and other disease such as type II diabetes and osteo-
porosis (Clevers, 2006; Klaus and Birchmeier, 2008; Clevers andNusse,
2012). MiRNA_148a has been shown to regulate adipogenesis through
modulation of Wnt/b-catenin signaling pathway (Qin et al., 2010),
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Figure 2 Forest plots showing the effects of risk alleles for SNPs in six loci reaching genome-wide signiﬁcance for association with all endometriosis and
two loci reaching borderline genome-wide signiﬁcance with only Stage III/IV cases in the meta-analysis. BBJ_Rep, BioBank Japan replication.
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emphasizing thepotentially important roleof this pathway forbothendo-
metriosis and fat distribution. More distant candidate genes for this
7p15.2 endometriosis association signal include HOXA10 (Homeobox
A10) andHOXA11 (HomeoboxA11)which are1.35Mbdownstream.
HOXA10 and HOXA11 are members of the homeobox A family of
transcription factors that play a role in uterine development (Taylor
et al., 1999; Wu et al., 2005). It is possible that the 7p15.2 signal inﬂu-
ences the regulation of interactive expression of a number of these
genomic loci; functional studies targeting this region will need to be con-
ducted to further elucidate its role in endometriosis pathogenesis.
Figure 3 Linkage disequilibrium structure for the region containing rs1537377, rs1333049 and rs10965235 in/near CDKN2BAS on chromosome 9 in
individuals of European ancestry (bottom panel) and of Japanese ancestry (top panel) (Source: http://hapmap.ncbi.nlm.nih.gov).
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Two further inter-genic loci did not reach genome-wide signiﬁcance of
association with endometriosis on meta-analysis, even when allowing
for heterogeneic effects across studies. Rs6734792 on 2q23.3, P ¼
2.2 × 1026 with all-stage endometriosis, is located 280 kb upstream
of RND3 (Rho Family GTPase 3). The signal showed similar strength of
association for all-stage and Stage III/IV endometriosis, implying a poten-
tial role in the aetiology of both minimal/mild and moderate/severe
disease. RND3 encodes a member of a subgroup of Rho family of small
GTP-binding proteins. RhoGTPases are key regulators of the actin cyto-
skeleton and stress ﬁbre formation. In addition, RND3 is also involved in
the regulation of cell-cycle progression, cell transformation (Chardin,
2006) and cell migration (Guasch et al., 1998). The third inter-genic
signal, rs4141819 on 2p14 (borderline signiﬁcant with P ¼ 9.2 × 1028
in Stage III/IV-enriched analysis) is located 227 kb away from ETAA1
(Ewing’s tumor-associated antigen 1) that encodes a tumour-speciﬁc
cell surface antigen in Ewing family of tumours (EFTs). EFTs is a group
of cancers that form in bone or soft tissue that share common features
as they develop from the same type of stem cell in the body (Borowski
et al., 2006). Rs4141819 is located in an intronic region of a long non-
coding RNA (lncRNA) AC007422.1, which is 118 kb long. Non-coding
RNAs are functional RNAmolecules that arenot translated intoproteins
but have a regulatory role in gene expression. The biological role of this
particular lncRNA is not yet known.
The remaining seven variants in six loci are located in or near
(within 50 kb) genes (Fig. 4): WNT4, GREB1, FN1, ID4, CDKN2B-AS1
and VEZT. These variants are likely to be involved in the ‘cis’-regulation
of expression of neighbouring genes and/or transcripts. The current
knowledge on the biological function of the implicated genes, which
vary from WNT4 and FN1 in developmental pathways to functions of
VEZT,GREB1, ID4,NFE2L3, FN1,ETAA1 andCDKN2B-AS1 in carcinogen-
esis, is described below.
WNT4 (Wingless-type MMTV integration site family member 4)
Rs7521902 is located21 kbup/downstreamofWNT4 (Fig. 4).WNT4 is a
protein-coding gene that is vital for developmentof the female reproduct-
iveorgans. Inknockoutmice, the lossofWNT4 leads tocompleteabsence
of the Mu¨llerian duct and its derivatives (Vainio et al., 1999). A previous
study investigated the expression of genes playing decisive roles during
the female reproductive tract development includingWNT4 in peritoneal
tissue from endometriosis cases and controls. They showed that WNT
genes are expressed in normal peritoneum in addition to endometrium,
suggesting that endometriosis can arise throughmetaplasia and can in the
process make use of the developmental steps involved in the embryonic
development of the female reproductive tract (Gaetje et al., 2007). As
mentioned before, Wnt signaling is important for epithelial–stromal cell
communication in the endometrium, and is likely to be important for
Figure4 Diagrams showing the9 genes closest to eachof the11endometriosis SNPs included in themeta-analysis. Exons (coding regions) arepresented
with grey coloured boxes; lines between the exons present introns (non-coding genic regions); emptywhite boxes at the ends of the genes represent the 3′
and 5′ UTR regions. Each endometriosis SNP is illustrated in red, along with its distance to the genewhere relevant (red arrows). SNPs genomewide asso-
ciatedwith other trait/disease associations, that are in linkage disequilibrium (r2 . 0.2) with any of the endometriosis SNPs are illustrated in blue. See Sup-
plementary data, Table SI for a complete list of all published SNP associations for these genomic regions including independent signals.
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endometrial development, differentiation and embryonic implantation
(Tulac et al., 2003). Furthermore, the endometriosis variant rs7521902
has also been genome-wide signiﬁcantly associated with bone mineral
density (Estrada et al., 2012), highlighting this variant as a potential pleio-
tropic locus (Fig. 4).
GREB1 (Growth regulation by estrogen in breast cancer 1)
Rs13394619 is located in an intronic region between exon 9 and exon 10
in GREB1. GREB1 encodes for an early response gene in the estrogen
regulation pathway that is involved in hormone-dependent breast
cancer cell growth (Rae et al., 2005). Furthermore, Pellegrini et al.
(2012) showed increased expression of GREB1 in peritoneal eutopic
endometriotic lesions comparedwith eutopic endometrium, implicating
its transcription in estrogen-dependent growth in endometriosis. The
underlying biological mechanism by which GREB1 plays a role in
hormone-responsive tissues especially estrogen-stimulated cell prolifer-
ation in endometriosis remains to be elucidated. The GREB1 region har-
bours many other SNPs reported to be genome-wide signiﬁcantly
associated with other traits and conditions, with GREB1 in particular
associated with obesity-related traits (Supplementary data, Table SI).
However, none of these SNPs are in LD with endometriosis SNP
rs13394619.
FN1 (Fibronectin 1)
Rs1250248 is located in an intronic region between exon 10 and exon 11
in FN1 (Fig. 4). FN1 is involved in cell adhesion and migration processes
including embryogenesis, wound healing, blood coagulation, host
defense and metastasis (Pankov and Yamada, 2002). Recently, it has
been shown that SOX2, a gene encoding a transcription factor that
targets FN1, is a key gene regulating cell migration in ovarian cancer
(Lou et al., 2013). Furthermore, an in vitro studyhas shown that FN1mod-
ulates CpG motif-dependent cytokine production in macrophages,
supressing the immune resposiveness through TLR9 pathway (Yoshida
et al., 2012). The FN1 region has been associated with many other
traits in GWASs (Supplementary data, Table SI); however, none of
these SNPs are in LD with endometriosis SNP rs1250248.
ID4 (Inhibitor of DNA binding 4)
Rs7739264 is located in an intronic region of lncRNA RP1–167F1.2
(794 bp), for which the biological function remains to be discovered. It
is located 52 kb downstream of ID4 (Fig. 4). ID4 is an ovarian oncogene
that is over-expressed inmost primary ovarian cancers but not in normal
ovary, fallopian tube and other tissues. Furthermore, it has been impli-
cated, through methylation-related regulatory pathways, in breast car-
cinogenesis (Verschuur-Maes et al., 2012) and is overexpressed in
most ovarian, endometrial and breast cancer cell lines (Ren et al.,
2012). Potential mechanisms by which ID4 induces transformation
include, through regulation of HOXA9 and CDKN1A (cyclin-dependent
kinase inhibitor 1A), transcriptional programmes to disrupt the normal
regulation of cell proliferation and differentiation (Ren et al., 2012).
HOXA genes have been shown to play essential roles in specifying region-
al differentiation of the Mu¨llerian duct into oviduct, uterus, cervix and
vagina (Kobayashi and Behringer, 2003). The region around endometri-
osis SNP rs7739264 contains a large number of reported SNPs asso-
ciated with different traits and conditions in GWASs (Supplementary
data, Table SI), none of which are in LD with rs7739264.
CDKN2B-AS1 (Cyclin-dependent kinase inhibitor 2B antisense RNA)
Rs1537377 is located 48 kb upstream of CDKN2B-AS1, while rs1333049
is located in the 3′UTR region of the gene and rs10965235, that ismono-
morphic is in theEuropeanpopulations, is in the intronbetweenexons16
and 17 of the gene (Fig. 4). The CDKN2B-AS1 locus encodes for cyclin-
dependent kinase inhibitor 2B antisense RNA. In the same LD block
with this gene are CDKN2A (P16), CDKN2B (P15) and ARF (P14), which
are all recognized tumour suppressor genes. CDKN2B-AS1 has been
shown to be involved in the regulation of CDKN2B, CDKN2A and ARF
expression (Pasmant et al., 2007; Jarinova et al., 2009; Liu et al., 2009).
Inactivation of CDKN2A, through loss of heterozygosity or hypermethy-
lationof its promoter, hasbeen reported in endometriosis andendomet-
rial cancer (Goumenou et al., 2000; Martini et al., 2002; Guida et al.,
2009). SNPs in or near the CDKN2B-AS1 locus have been associated
with many other traits and disease (Supplementary data, Table SI),
with a number in LD (r2. 0.2) with the endometriosis SNPs (Fig. 4),
including rs1063192 and rs2157719 with glaucoma (Osman et al.,
2012; Wiggs et al., 2012), rs4977756 with glioma (Rajaraman et al.,
2012), rs10757269 with ankle-brachial index (Murabito et al., 2012),
rs6475606 and rs10757272 with intracranial aneurysm (Foroud et al.,
2012; Low et al., 2012), rs1537370 with coronary artery calciﬁcation
(van Setten et al., 2013) and rs7865618, rs10757274, rs1333042 and
rs944797 with coronary heart disease (Wild et al., 2011; Lu et al.,
2012; Takeuchi et al., 2012; Lee et al., 2013); because of these diverse
associations, its function is an area of research for many investigators.
VEZT (Vezatin)
Rs10859871 is located 17 kb upstream of VEZT (Fig. 4). The locus was
the second signal that showed similar strength of association for
Stage III/IV disease [OR ¼ 1.19 (95% CI: 1.11–1.27), P ¼ 6.8 ×
1027] versus all endometriosis [OR ¼ 1.18 (95% CI: 1.13–1.22, P ¼
4.8 × 10215]. VEZT encodes an adherens junction transmembrane
protein. Vezatin expression has been shown to be down-regulated in
gastric cancer patients through methylation of its promoter (Guo et al.,
2011;Miao et al., 2013). It is a putative tumour suppressor gene, targeting
cell migration and invasion genes, growth genes, cellular adhesion genes
and a functionally validated cell cycle progression gene called TCF19
(transcription factor 19) (Miao et al., 2013). TCF19was found to be asso-
ciated with lymphocyte count, mean cell hemoglobin, white blood cell
count, hematocrit count and eosinophil count (Ferreira et al., 2009)
hinting at apotential roleofTCF19 regulation throughVEZT inmaintaining
immunological balance. In the Japanese population, Rs10859871 is in
LD with rs12310399 (r2 ¼ 0.57; Fig. 4, Supplementary data, Table SI)
located 121 kb downstream of VEZT, a variant that has been associated
with adverse response to chemotherapy (Low et al., 2013) (Fig. 4).
Conclusions and future directions
Our meta-analysis demonstrated directionally consistent, genome-wide as-
sociation of SNPs in six genetic loci with endometriosis across European an-
cestry populations in Australia, Belgium, Italy, the UK, the USA, as well as
Japanese ancestry populations: rs12700667 on 7p15.2, rs7521902 near
WNT4, rs10859871 near VEZT, rs1537377 near CDKN2B-AS1, rs7739264
near ID4 and rs13394619 in GREB1. Five of the six loci showed stronger
effect sizes of association with Stage III/IV disease, with the exception of
VEZT. Of the remaining three loci, two (FN1 and inter-genic 2p14) were
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borderline genome wide signiﬁcant for association in Stage III/IV-only or
Stage III/IV-enriched analyses, respectively. Except for inter-genic
rs4141819 and rs6734792 on chromosome 2, none of the other SNPs/
loci showed signiﬁcant evidence of heterogeneity across datasets (P.
0.005) showing that the signiﬁcantly associated risk variants of endometriosis
are pertinent to all studied populations.
It was notable that of the 11 SNPs included in the meta-analysis, 5
were in LD (r2. 0.2)with an SNP that has also robustly been associated
with different diseases and traits in other GWASs: in or near WNT4
with bone mineral density; in CDKN2B-AS1 with glaucoma, glioma,
ankle-brachial index, intracranial aneurysm, coronary artery calciﬁcation
and coronary heart disease; in VEZT with adverse response to chemo-
therapy and in 7p15.2with fat distribution. This information is important,
as the investigation of other established disease variants in genomic
regions associatedwith endometriosis can aid in revealing the potentially
biologicalmechanisms throughwhich the variantmayactuponendomet-
riosis pathogenesis, and can lead to new investigations of joint aetiology
and co-morbidity.
Detailed and standardized disease phenotype
Our results showing stronger associations with Stage III/IV endometri-
osis emphasize the importance of detailed sub-phenotype collection
to allow analyses for the identiﬁcation of further variants associated
with sub-types of endometriosis. Currently, datasets with detailed surgi-
cal and clinical sub-phenotype information are not available on a large
scale, but such information collected in a standardized manner is
required to enable future genomic research. The globalWERFEndomet-
riosis Biobanking and Phenome Harmonisation Project (EPHect), cur-
rently involving 32 clinical and basic endometriosis research centres
and 3 industrial collaborators, is developing freely available data collec-
tion tools to enable standardized data collection, and thus foster future
collaborative analyses across endometriosis research centres (http
://www.endometriosisfoundation.org/ephect).
Larger sample sizes
Although this may be surprising, the sample sizes of the endometriosis
GWASs to date are at the lower end of GWASs in other complex
disease ﬁelds, and an increased sample size for genome-wide
meta-analysis of GWAS studies is predicted to increase the number of
genome-wide signiﬁcant loci (Visscher et al., 2012). For instance,
recent meta-GWAS analyses of type 2 diabetes have included close to
100 000 cases, and have identiﬁed around 65 genome-wide signiﬁcant
variants associated with disease (Morris et al., 2012); the count of
genome-wide signiﬁcant loci associated with inﬂammatory bowel
disease, involving up to 37 000 cases and controls, is as high as 163
(Jostins et al., 2012). This further emphasizes the need for collaborations
between centres, which collect standardized characteristics of the
disease as well as detailed symptoms, to increase endometriosis case
numbers and allow further GWAS datasets to be generated. Undoubt-
edly, larger GWASs and meta-analyses in different populations will
allow the detection of additional common causal variants of modest
effects on endometriosis risk.
Better coverage of genomic variation
GWASs are limitedwith regard to their ability to detect only the effect of
common variants (MAF . 0.05). It is likely that some of the unexplained
genetic variationmaybedue to rarer variants (MAF, 0.05), either single
sited or structural, that are not captured by current GWA genotyping
arrays (Visscher et al., 2012). As mentioned before, family-based
linkage studies of endometriosis have successfully identiﬁed two
linkage regions that are likely to harbour rare causal variants, on chromo-
some 10q26 (Treloar et al., 2005) and on chromosome 7p13-15 (Zon-
dervan et al., 2007). Systematic resequencing studies of these regions are
required to identify the rare variants involved.
Functional studies
To understand the roles of the identiﬁed genetic variants in endometri-
osis, functional studies are needed tissues relevant to endometriosis,
such as eutopic and ectopic endometrium. Functional studies aim to
understand how changes in the DNA level of variation translate to the
(regulation of) RNA transcript levels, protein levels and metabolite
levels. These studies are crucial in revealing the biological mechanisms
by which the genetic variations detected are causally related to the
disease end-points. To allow replication of ﬁndings between studies,
and collaborative analyses, centres collecting tissues for the purpose of
endometriosis research need to use similar, standard-operating proto-
cols (SOPs) for collection, processing and storage of samples. In addition
to guidelines and standards for data collection, the EPHect also provides
freely available consensus SOPs for biological sample collection that will
allow large-scale collaborative functional studies contributing to bio-
marker and drug target discovery research.
Supplementary data
Supplementary data are available at http://humupd.oxfordjournals.org/.
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